Anyway, the different regulation of Long and Short RECK splice variants in CTR subjects, CAD and AMI patients indicate that their expression level might be a good genomic biomarker of clinical outcome in coronary artery disease patients. This evidence concerns the gene RECK and coronary artery disorder.